Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
2ONE Labs and Performance Plus Marketing, sellers of 2ONE Nicotine Pouches, Allege Fraud and Seek Damages in 'Zone' Trademark Infringement Case Against Imperial Brands
Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy
Copenhagen Infrastructure Partners takes FID and commences construction on 1,100 MWh battery energy storage project in Chile
CMO Council Names Daniel Ng to New Role as Advisory Board President and Regional Relationship Officer in Asia